WHO Officially Labels XBB.1.16 a COVID ‘Variant of Interest’

It has grown exponentially since first appearing in India in January, and now accounts for 4.2% of global cases and 9.6% of cases in the U.S. The CDC has not issued an official watchlist designation for Arcturus.

​ 

NEWSLETTER